Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23519403)

1.

Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis.

Tu EY, Shoff ME, Gao W, Joslin CE.

JAMA Ophthalmol. 2013 May;131(5):595-600. doi: 10.1001/jamaophthalmol.2013.1644.

PMID:
23519403
2.

Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.

Kowalski RP, Abdel Aziz S, Romanowski EG, Shanks RM, Nau AC, Raju LV.

JAMA Ophthalmol. 2013 Nov;131(11):1459-62. doi: 10.1001/jamaophthalmol.2013.5062.

3.

Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.

Mrva M, Garajová M, Lukáč M, Ondriska F.

J Parasitol. 2011 Jun;97(3):538-40. doi: 10.1645/GE-2669.1. Epub 2010 Oct 28.

PMID:
21506779
4.

The reculture technique: individualizing the treatment of Acanthamoeba keratitis.

Wysenbeek YS, Blank-Porat D, Harizman N, Wygnanski-Jaffe T, Keller N, Avni I.

Cornea. 2000 Jul;19(4):464-7.

PMID:
10928758
5.

In vitro evaluations of topical agents to treat Acanthamoeba keratitis.

Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, Suzuki T, Inoue Y, Ohashi Y, Asari S, Iwatani Y.

Ophthalmology. 2014 Oct;121(10):2059-65. doi: 10.1016/j.ophtha.2014.04.013. Epub 2014 May 29.

PMID:
24880905
6.

Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.

Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Valladares B, Piñero JE, Lorenzo-Morales J.

Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2111-7. doi: 10.1007/s00417-013-2371-y. Epub 2013 May 19.

PMID:
23686225
7.

The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy.

Kowalski RP, Kowalski BR, Romanowski EG, Mah FS, Thompson PP, Gordon YJ.

Am J Ophthalmol. 2006 Nov;142(5):730-5. Epub 2006 Sep 15.

PMID:
16978577
8.

A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.

Vasseneix C, Gargala G, François A, Hellot MF, Duclos C, Muraine M, Benichou J, Ballet JJ, Brasseur G, Favennec L.

Cornea. 2006 Jun;25(5):597-602.

PMID:
16783150
9.

Development of standardized methods for assessing biocidal efficacy of contact lens care solutions against Acanthamoeba trophozoites and cysts.

Kilvington S, Lam A.

Invest Ophthalmol Vis Sci. 2013 Jul 5;54(7):4527-37. doi: 10.1167/iovs.13-11927.

PMID:
23745008
10.

In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.

Haas W, Pillar CM, Hesje CK, Sanfilippo CM, Morris TW.

J Antimicrob Chemother. 2011 Apr;66(4):840-4. doi: 10.1093/jac/dkq531. Epub 2011 Jan 27.

11.

In vitro transcorneal penetration of metronidazole and its potential use as adjunct therapy in Acanthamoeba keratitis.

van der Bijl P, van Eyk AD, Seifart HI, Meyer D.

Cornea. 2004 May;23(4):386-9.

PMID:
15097135
12.

[Study on the effect of H2O2 against Acanthamoeba in vitro].

Zhao QF, Gao XL, Qian M.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21(4):218-20. Chinese.

PMID:
14628372
13.

Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.

Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M.

Eye (Lond). 1996;10 ( Pt 4):413-21.

PMID:
8944089
14.

The effect of propolis in experimental Acanthamoeba keratitis.

Vural A, Polat ZA, Topalkara A, Toker MI, Erdogan H, Arici MK, Cetin A.

Clin Experiment Ophthalmol. 2007 Nov;35(8):749-54.

PMID:
17997780
15.

Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba.

Lim L, Coster DJ, Badenoch PR.

Clin Experiment Ophthalmol. 2000 Apr;28(2):119-24.

PMID:
10933775
16.

Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.

Polat ZA, Vural A.

Parasitol Res. 2012 May;110(5):1945-50. doi: 10.1007/s00436-011-2722-8. Epub 2011 Dec 9.

PMID:
22160252
17.

Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.

Polat ZA, Karakus G.

Parasitol Res. 2013 Feb;112(2):529-33. doi: 10.1007/s00436-012-3163-8. Epub 2012 Oct 10.

PMID:
23052789
18.

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.

Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK.

Ophthalmology. 2003 Aug;110(8):1593-600.

PMID:
12917179
19.

Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.

Hay J, Kirkness CM, Seal DV, Wright P.

Eye (Lond). 1994;8 ( Pt 5):555-63.

PMID:
7835453
20.

Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.

Mafra CS, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Taguchi FM, Foronda AS, Carvalho FR, de Freitas D.

Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6363-72. doi: 10.1167/iovs.13-11990.

PMID:
23900604
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk